I don't know that they knew it was only 30%, but I do know something doesn't smell right here. We had Sr. level management public lying touting the 50% effectiveness, made global regulatory filings based on that data...then several weeks later, on a second analysis with more patients we find its only 30% effective? that's a steep decline in a short period of time, with a patient population that was roughly double that of the initial analysis. what changed?? You can bet Mr. Davis will want some answers...Robert Davis & Caroline Litchfield should be investigated by the SEC. Total fraud when they said 50% knowing it was only 30%. The stock price went up 10% in a day, media was hyping it as a “GAME CHANGER” Management held a special teleconference stating, “This is our Keytruda moment” all the while they knew it was Snake Oil. SEC is coming down on big sales of stock when MRK went to $91 on bogus data. Heads will roll on this one Merckies.
meant to say "touting", not "lying touting"...I don't know that they knew it was only 30%, but I do know something doesn't smell right here. We had Sr. level management public lying touting the 50% effectiveness, made global regulatory filings based on that data...then several weeks later, on a second analysis with more patients we find its only 30% effective? that's a steep decline in a short period of time, with a patient population that was roughly double that of the initial analysis. what changed?? You can bet Mr. Davis will want some answers...
Never been more embarrassed to be a Merck ee since the Vioxx fiasco. TRUE STORY.
Chronic Care is supposed to get this Covid Pill. Now what are we going to do?
Belsomra: NOPE
Steglatro: NOPE
Verquvo: NOPE
Covid Pill: NOPE
Chronic Cough Drug: Doubtful
even if approved its a marginal drug, marginal revenueCough drug significant delay - may never see light if day.